Question 1

What are the key details for the project “Jubilant Pharma”?

Accepted Answer

The project “Jubilant Pharma” is an infrastructure initiative in the Raw Materials sector, located in India. Taiyo aggregates data on it from International Finance Corporation (IFC).

Question 2

What is the latest status of the project “Jubilant Pharma”?

Accepted Answer

The status recorded for “Jubilant Pharma” is completed.

Question 3

Who are the main government, EPC, and private stakeholders for “Jubilant Pharma”?

Accepted Answer

Taiyo maps the stakeholders of “Jubilant Pharma”: government bodies (International Finance Corporation (IFC)).

Question 4

What is the budget and commercial profile for the project “Jubilant Pharma”?

Accepted Answer

Taiyo normalizes the budget of “Jubilant Pharma” to USD 110000000.

Question 5

Where can I verify the source and access all details for “Jubilant Pharma”?

Accepted Answer

This Taiyo project page references International Finance Corporation (IFC) along with the original URL (https://disclosures.ifc.org/project-detail/SII/35027/jubilant-pharma). Taiyo standardizes official data into a consistent, searchable project profile.

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Original status	completed
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description	The proposed project (the Project) involves an IFC-led financing package that will help provide a counter cyclical and long-term financial support to Jubilant Pharma Limited, Singapore (JPL or the Company) and through JPL, to its parent company, Jubilant Life Sciences Limited, India (JLS or the Parent). JPL is a wholly owned subsidiary of JLS and with this financing, JLS plans to consolidate its pharmaceutical business under JPL. This financing package will help JLS to de-couple its pharmaceutical business from its life science ingredients (LSI) business and enhance shareholder value.
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

Jubilant Pharma

Project Information FAQ

Project Information

More Raw Materials projects in India